Roux-en-Y胃空肠吻合术在食管胃肌切开术后抗反流效果评估
本研究回顾性分析37例接受Roux-en-Y胃空肠吻合联合食管胃肌切开术的患者,中位随访18个月,92%实现食管保留,69%无症状,54%仍用PPI,结论认为RYGJ是肌切开术后合适的抗反流术式,且对肥胖患者有助体重控制。
要点
- RYGJ联合肌切开术后多数患者症状缓解,食管保留率92%。
- 术后27%需晚期再干预,54%仍需PPI,需长期监测。
- 术前BMI>35 kg/m²者平均总体重下降20.9%。
核心结论
- 多数接受RYGJ联合肌切开术的患者症状缓解,多数可实现食管保留。
- RYGJ是食管胃肌切开术后合适的抗反流手术,并为肥胖患者提供合理体重控制。
研究设计与样本
- 回顾性病历复习,从手术记录数据库识别37例接受Roux-en-Y胃空肠吻合联合食管胃肌切开术的患者。
- 中位年龄57岁,76%为女性,术前BMI>35 kg/m²者18例(49%)。
- 中位随访18个月(范围0至146个月)。
主要发现
- 主要症状为吞咽困难33例(89%),反流23例(62%),烧心16例(43%)。
- 34例(92%)实现食管保留,10例(27%)需晚期再干预。
- 监测内镜显示18/22例(82%)无糜烂性食管炎,1例新发Barrett食管。
- 当前使用PPI者20例(54%),末次随访时26例(69%)无症状。
- 术前BMI>35 kg/m²者平均总体重下降20.9%。
临床怎么用
- 对于食管胃肌切开术后需抗反流者,RYGJ可作为可选术式,尤其肥胖患者可能同时获益体重控制。
- 术后需长期监测反流症状、PPI使用及内镜表现,警惕再干预风险。
局限性
- 回顾性设计,样本量较小(37例),随访时间变异大(0至146个月)。
- 无对照组,无法比较RYGJ与其他抗反流术式的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Roux-en-Y gastrojejunostomy (RYGJ) is viewed as a salvage operation for fundoplication failure or obesity-related reflux, and we questioned it is long-term effectiveness in patients undergoing esophagogastric myotomy. METHODS: From an operative report database, we identified 37 patients who underwent a combination of Roux-en-Y gastrojejunostomy and esophagogastric myotomy, and retrospective chart review was performed. Dysphagia was the main presenting symptom, reported in 33 patients (89%), followed by regurgitation in 23 patients (62%) and reflux in 16 patients (43%). Sequence of operations was as follows: Myotomy then revisional Gastro-Jejunostomy (MGJ, N = 16); Concomitant Primary (CP, N = 6); Concomitant Revisional (CR, N = 8); and RYGJ then Myotomy (RM, N = 7). Of the MGJ group, five had Serra Doria esophagocardioplasty. RESULTS: The median age was 57 years with 76% female. Preoperative BMI > 35 kg/m2 was observed in 18 patients (49%): CP, 100%; CR, 63%; MGJ, 31%; RM, 14%. There were no perioperative leaks or reoperations. The median follow-up was 18 months (range 0 to 146). Esophageal salvage was accomplished in 34 patients (92%). Late reintervention was required in 10 patients (27%). In the MGJ group, two patients required esophagectomy, and three patients underwent reoperation for other indications: one for recurrent hiatal hernia, one for internal hernia, and one for removal of a remnant gastrostomy tube. In the CR group, two patients underwent dilations and one patient received botulinum toxin injection. In RM group, one patient underwent dilation, and one required esophagectomy. Surveillance endoscopy showed no erosive esophagitis in 18/22 patients (82%), and one patient had new Barrett's esophagus. Current proton pump inhibitor (PPI) use was observed in 20 patients (54%). At last follow-up, 26 (69%) of patients were symptom-free. In patients with preop BMI > 35 kg/m2, mean total body weight lost was 20.9%. No group had lower rates of reintervention, esophagitis, or PPI use. CONCLUSION: Most patients undergoing a combination of RYGJ and myotomy experience relief of their symptoms, with esophageal salvage possible in the majority. RYGJ is an adequate anti-reflux operation after esophagogastric myotomy and offers reasonable weight control in obese patients.
引用
- Korbitz H, Alomari M, Edwards MA, et al. Is Roux-en-Y gastrojejunostomy an adequate anti-reflux operation after esophagogastric myotomy? Surg Endosc. 2025. PMID: 40576776. doi:10.1007/s00464-025-11817-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。